Longeveron Inc.
LGVN- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001721484
No open-market purchases or sales by Longeveron Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $3.35M in total; no superinvestor holds it.
13F holders, Q2 2024
Institutional positions in Longeveron Inc. as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 21
- +9 vs. Q1 2024
- Shares held
- 331.3K
- +281.5K (+565.6%) vs. Q1 2024
- Total value
- $534.1K
- +$372.3K (+230.2%) vs. Q1 2024
- New holders
- 12
- 5 more added
- Sold out
- 3
- 3 more reduced
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting LGVN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $3.35M |
| Q1 2026 | 31 | $2.37M |
| Q4 2025 | 30 | $520.6K |
| Q3 2025 | 29 | $783.1K |
| Q2 2025 | 25 | $868.1K |
| Q1 2025 | 21 | $790.6K |
| Q4 2024 | 24 | $844.4K |
| Q3 2024 | 19 | $512.3K |
| Q2 2024 | 21 | $534.1K |
| Q1 2024 | 12 | $161.7K |
| Q4 2023 | 22 | $3.42M |
| Q3 2023 | 19 | $1.37M |
| Q2 2023 | 21 | $2.71M |
| Q1 2023 | 16 | $1.13M |
| Q4 2022 | 17 | $1.45M |
| Q3 2022 | 18 | $1.64M |
| Q2 2022 | 14 | $2.24M |
| Q1 2022 | 14 | $9.59M |
| Q4 2021 | 19 | $5.55M |
| Q3 2021 | 13 | $1.07M |
| Q2 2021 | 12 | $2.96M |
| Q1 2021 | 10 | $561.0K |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Longeveron Inc.; share changes are against Q1 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Renaissance Technologies LLC | 146,700 | $236.2K | 0.00% | +146,700 | New |
| Two Sigma Investments, LP | 46,041 | $74.1K | 0.00% | +46,041 | New |
| Geode Capital Management, LLC | 30,994 | $49.9K | 0.00% | +30,994 | New |
| Capital Investment Advisory Services, LLC | 26,525 | $42.7K | 0.00% | +26,525 | New |
| Citadel Advisors LLC | 22,485 | $36.2K | 0.00% | +22,485 | New |
| Squarepoint Ops LLC | 17,831 | $28.7K | 0.00% | +17,831 | New |
| Creative Planning | 11,200 | $18.0K | 0.00% | +267+2.4% | Added |
| BlackRock Inc. | 10,016 | $16.1K | 0.00% | −1,125−10.1% | Reduced |
| Vontobel Holding Ltd. | 10,000 | $16.1K | 0.00% | +10,000 | New |
| Tower Research Capital LLC (TRC) | 4,899 | $7.89K | 0.00% | +2,304+88.8% | Added |
| Bank of America Corp | 1,682 | $2.71K | 0.00% | +1,682 | New |
| Morgan Stanley | 1,409 | $2.27K | 0.00% | +1,400+15,555.6% | Added |
| EverSource Wealth Advisors, LLC | 481 | $1.51K | 0.00% | +481 | New |
| Wells Fargo & Company | 464 | $747 | 0.00% | −7−1.5% | Reduced |
| The PNC Financial Services Group, Inc. | 297 | $478 | 0.00% | 00.0% | Unchanged |
| Qube Research & Technologies Ltd | 100 | $161 | 0.00% | +100 | New |
| Naples Money Management LLC | 100 | $157 | 0.00% | +100 | New |
| LGT Financial Advisors LLC | 36 | $58 | 0.00% | +1+2.9% | Added |
| UBS Group AG | 1 | $2 | 0.00% | −11−91.7% | Reduced |
| FMR LLC | 1 | $2 | 0.00% | +1 | New |
| Royal Bank of Canada | 53 | $0 | 0.00% | +43+430.0% | Added |
| Vanguard Group Inc | 0 | $0 | 0.00% | −24,132−100.0% | Sold out |
| JPMorgan Chase & Co | 0 | $0 | 0.00% | −129−100.0% | Sold out |
| Householder Group Estate & Retirement Specialist, LLC | 0 | $0 | 0.00% | −10−100.0% | Sold out |